A detailed history of Anchor Capital Advisors LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Anchor Capital Advisors LLC holds 142,912 shares of ABT stock, worth $16.5 Million. This represents 0.46% of its overall portfolio holdings.

Number of Shares
142,912
Previous 144,513 1.11%
Holding current value
$16.5 Million
Previous $15 Million 8.5%
% of portfolio
0.46%
Previous 0.43%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

SELL
$100.07 - $118.13 $160,212 - $189,126
-1,601 Reduced 1.11%
142,912 $16.3 Million
Q2 2024

Aug 06, 2024

BUY
$100.73 - $112.44 $2.37 Million - $2.64 Million
23,482 Added 19.4%
144,513 $15 Million
Q1 2024

May 07, 2024

SELL
$109.52 - $120.96 $1.46 Million - $1.61 Million
-13,319 Reduced 9.91%
121,031 $13.8 Million
Q4 2023

Feb 05, 2024

SELL
$90.19 - $110.4 $111,204 - $136,123
-1,233 Reduced 0.91%
134,350 $14.8 Million
Q3 2023

Nov 09, 2023

SELL
$95.53 - $114.62 $346,391 - $415,612
-3,626 Reduced 2.6%
135,583 $13.1 Million
Q2 2023

Aug 04, 2023

SELL
$100.78 - $112.29 $352,125 - $392,341
-3,494 Reduced 2.45%
139,209 $15.2 Million
Q1 2023

May 03, 2023

SELL
$96.86 - $114.01 $39,422 - $46,402
-407 Reduced 0.28%
142,703 $14.5 Million
Q4 2022

Feb 10, 2023

SELL
$95.06 - $111.52 $596,311 - $699,564
-6,273 Reduced 4.2%
143,110 $15.7 Million
Q3 2022

Nov 09, 2022

SELL
$96.76 - $112.03 $694,736 - $804,375
-7,180 Reduced 4.59%
149,383 $14.5 Million
Q2 2022

Aug 04, 2022

SELL
$102.07 - $123.37 $978,443 - $1.18 Million
-9,586 Reduced 5.77%
156,563 $17 Million
Q1 2022

May 06, 2022

SELL
$114.02 - $139.04 $72,630 - $88,568
-637 Reduced 0.38%
166,149 $19.7 Million
Q4 2021

Feb 10, 2022

SELL
$115.53 - $141.46 $383,097 - $469,081
-3,316 Reduced 1.95%
166,786 $23.5 Million
Q3 2021

Nov 02, 2021

BUY
$116.66 - $129.06 $141,975 - $157,066
1,217 Added 0.72%
170,102 $20.1 Million
Q2 2021

Aug 16, 2021

BUY
$105.79 - $124.53 $177,727 - $209,210
1,680 Added 1.0%
168,885 $19.6 Million
Q1 2021

May 14, 2021

BUY
$108.84 - $128.23 $1.03 Million - $1.22 Million
9,502 Added 6.03%
167,205 $20 Million
Q4 2020

Feb 08, 2021

BUY
$105.0 - $114.42 $415,590 - $452,874
3,958 Added 2.57%
157,703 $17.3 Million
Q3 2020

Nov 13, 2020

BUY
$91.64 - $111.29 $143,508 - $174,280
1,566 Added 1.03%
153,745 $16.7 Million
Q2 2020

Aug 10, 2020

SELL
$76.57 - $98.0 $5.15 Million - $6.59 Million
-67,272 Reduced 30.65%
152,179 $13.9 Million
Q1 2020

May 07, 2020

SELL
$62.82 - $91.86 $443,069 - $647,888
-7,053 Reduced 3.11%
219,451 $17.3 Million
Q4 2019

Jan 27, 2020

BUY
$78.51 - $87.4 $1.92 Million - $2.14 Million
24,449 Added 12.1%
226,504 $19.7 Million
Q3 2019

Oct 25, 2019

SELL
$81.84 - $88.74 $630,249 - $683,386
-7,701 Reduced 3.67%
202,055 $16.9 Million
Q2 2019

Aug 01, 2019

SELL
$72.88 - $85.0 $482,174 - $562,360
-6,616 Reduced 3.06%
209,756 $17.6 Million
Q1 2019

May 09, 2019

SELL
$66.22 - $80.06 $11.2 Million - $13.5 Million
-168,591 Reduced 43.79%
216,372 $17.3 Million
Q4 2018

Feb 04, 2019

SELL
$65.56 - $74.27 $350,155 - $396,676
-5,341 Reduced 1.37%
384,963 $27.8 Million
Q3 2018

Oct 31, 2018

SELL
$60.81 - $73.36 $1.05 Million - $1.27 Million
-17,271 Reduced 4.24%
390,304 $28.6 Million
Q2 2018

Aug 07, 2018

SELL
$57.57 - $63.54 $2.33 Million - $2.57 Million
-40,405 Reduced 9.02%
407,575 $24.9 Million
Q1 2018

May 09, 2018

SELL
$56.27 - $63.62 $4.6 Million - $5.21 Million
-81,816 Reduced 15.44%
447,980 $26.8 Million
Q4 2017

Feb 06, 2018

SELL
$53.68 - $57.47 $1.14 Million - $1.22 Million
-21,297 Reduced 3.86%
529,796 $30.2 Million
Q3 2017

Nov 06, 2017

BUY
$48.06 - $53.64 $26.5 Million - $29.6 Million
551,093
551,093 $29.4 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $202B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Anchor Capital Advisors LLC Portfolio

Follow Anchor Capital Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Anchor Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Anchor Capital Advisors LLC with notifications on news.